Enanta Pharmaceuticals

ENTANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$400.409 M

$13.77 +3.22%

Close of 7 Aug 2026

Revenue

$65.3M

#2663 by revenue

Earnings

-$81.9M

Loss-making

Shares outstanding

29,078,380

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#221KamadaKMDA$419.4M
#222Abeona TherapeuticsABEO$412.6M
#223Enanta PharmaceuticalsENTA$400.4M
#224Upstream BioUPB$394.5M
#225Rocket PharmaceuticalsRCKT$394.2M

Where these numbers come from

Share counts and financials for Enanta Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.